Sharekhan's research report on Marico
Marico's consolidated revenue declined by ~7% due to an 8% decline (volume decline was 3%) in India business and 5% decline in domestic business. Gross margin improved by 23 bps, while lower advertisement spends and other expenses led to 126 bps improvement in OPM to 18.9%. The company is Focusing on delivering healthy growth in the medium term through revamp strategies of providing value preposition in core categories, launching new products in the health and hygiene space, stringent cost-saving initiatives, and expanding the direct distribution reach.
Outlook
The stock is currently trading at discounted valuation of 30x its FY2022E EPS. In view of long-term growth prospects and discounted valuation, we maintain Buy with a revised PT of Rs. 325.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
